Fibrocell Science Inc buy melinda
Start price
09.09.17
/
50%
€3.22
Target price
19.12.17
€4.40
Performance (%)
-78.57%
End price
19.12.17
€0.69
Summary
This prediction ended on 19.12.17 with a price of €0.69. The BUY prediction by melinda for Fibrocell Science Inc performed very badly with a performance of -78.57%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fibrocell Science Inc | - | - | - | - |
| iShares Core DAX® | 1,01 % | 2,70 % | 4,36 % | 51,69 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % | 18,00 % | 67,99 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % | 40,91 % | 57,11 % |
| iShares S&P 500 | -2,72 % | -1,75 % | 16,97 % | 58,87 % |
Comments by melinda for this prediction
In the thread Fibrocell Science Inc diskutieren
Phase 1/2 Einleitung der Therapie am 23. Februar angekündigt, 2017. Phase 1 Daten für 3Q 2017
(Vom Mitglied beendet)
Stopped prediction by melinda for Fibrocell Science Inc
Fibrocell Science Inc
Start price
Target price
Perf. (%)
€2.90
09.09.17
09.09.17
€3.97
19.12.17
19.12.17
-78.57%
19.12.17
19.12.17
Fibrocell Science Inc
Start price
Target price
Perf. (%)
€3.08
26.06.17
26.06.17
€3.43
27.06.17
27.06.17
11.70%
27.06.17
27.06.17